UnicomIG
0.1.0 - ci-build

UnicomIG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/unicom-ig/ and changes regularly. See the Directory of published versions

Example Bundle: Norvasc-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL

Norvasc® 5 mg Tablett

MPID: SE-100023206-00011287

Full name: Norvasc® 5 mg Tablett

- Invented name part: Norvasc®

- Strength part: 5 mg

- Pharmaceutical dose form part: Tablett

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Tablet

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000095065 amlodipine
  • C08CA01 amlodipine

Marketing Authorisation 1 of 1

Authorisation number: 11287

Region: Kingdom of Sweden

Marketing authorisation holder: Upjohn EESV

Identifier:

  • LOC-100032008

Status: Valid (1991-01-18)

Package 1 of 1

PCID:

Description:
Blister, 98 tabletter (kalenderförpackning)

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 98 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 7 Blister (PolyVinyl Chloride) (PolyVinylidene Chloride) (Aluminium)

Containing: 14 Tablet

Manufactured Item

Dose form: Tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Amlodipine besilate

Presentation strength: 6.944 milligram(s) / 1 unit(s)

Reference strength:
Amlodipine 5 milligram(s) / 1 unit(s)

Administrable Product (1 of 1)

Dose form: Tablet

Unit of presentation: Tablet

Route of administration:

  • Oral use

Ingredients:

Ingredient

Role: Active

Substance: Amlodipine besilate

Presentation strength: 6.944 milligram(s) / 1 unit(s)

Reference strength:
Amlodipine 5 milligram(s) / 1 unit(s)